REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ix Biopharma Ltd (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Ix Biopharma Ltd Profile Updated: March 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2026 Available in: English Download a sample report

Ix Biopharma Ltd is based in Singapore, with the head office in Singapore. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on September 11, 2026. Ix Biopharma Ltd currently employs 59 (2024) people. The latest financial highlights indicate a net sales revenue drop of 11.77% in 2026. Its’ total assets recorded a growth of 129.34%. In 2026, Ix Biopharma Ltd’s net profit margin increased by 13.92%.

Headquarters
20 Collyer Quay, 11-07
Singapore; Singapore; Postal Code: 049319

Contact Details: Purchase the Ix Biopharma Ltd report to view the information.

Website: http://www.ixbiopharma.com

Basic Information
Total Employees:
Purchase the Ix Biopharma Ltd report to view the information.
Outstanding Shares:
Purchase the Ix Biopharma Ltd report to view the information.
Financial Auditors:
Purchase the Ix Biopharma Ltd report to view the information.
Incorporation Date:
September 11, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
24.44%
Purchase this report to view the information.
7.52%
Subsidiaries
Arrow Property Trust (Australia)
100%
Entity Health Pte Ltd (Hong Kong SAR, China)
100%
Ix Biopharma Europe Limited (Ireland)
100%
Company Performance
Financial values in the chart are available after Ix Biopharma Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-11.77%▼
Total Operating Revenue
-13.7%▼
Operating Profit
-52.94%▼
EBITDA
-62.42%▼
Net Profit/Loss for the Period
21.18%▲
Total Assets
129.34%▲
Total Equity
4118.08%▲
Operating Profit Margin
-60.73%▼
Net Profit Margin
13.92%▲
Return on Equity (ROE)
2726.44%▲
Debt / Equity
-1579.31%▼
Quick Ratio
1.37%▲
Cash Ratio
1.37%▲

Similar companies

Pfizer Asia Manufacturing Pte. Ltd.
 
Cardinal Health Singapore 225 Pte. Ltd.
Edwards Lifesciences (Singapore) Pte. Ltd.
 
Abbott Manufacturing Singapore Private Limited
Amgen Singapore Manufacturing Pte. Ltd.
 
Ab Sciex Pte. Ltd.
Nin Jiom (Singapore) Pte. Ltd.
 
Medochemie Singapore Pte. Ltd.
Cerecin Pte. Ltd.
 
Ual Biotech Pte. Ltd.
Nutristar Asia Pte. Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo